<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137353">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01313156</url>
  </required_header>
  <id_info>
    <org_study_id>AKS#1833</org_study_id>
    <nct_id>NCT01313156</nct_id>
  </id_info>
  <brief_title>LUPS-Lipids and Glucose Under Prospective Surveillance</brief_title>
  <acronym>LUPS</acronym>
  <official_title>Lipids and Glucose Under Prospective Surveillance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asklepios proresearch</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>City of Hamburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universit채tsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asklepios proresearch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, non-randomized cohort study to analyse genetic variations, dietary patterns,
      perceived stress and anxiety and early changes in lipid metabolism leading to the metabolic
      syndrome and type 2 diabetes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The LUPS-study is a collaboration between Asklepios Clinics Hamburg GmbH and University
      Clinic Hamburg Eppendorf, Germany. This study is assessing a multitude of serum biomarkers,
      anthropometrics, dietary habits, physical activity, perceived stress along with genetic
      information from &quot;healthy workers&quot; (25-60years) to better understand phenotype-genotype
      associations leading to MetS and type 2 diabetes.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2008</start_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Metabolic Syndrome, Type 2 Diabetes</measure>
    <time_frame>10 years</time_frame>
    <description>assessing risk factors, e.g. HDL, BMI, Blood Pressure, FPG</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1962</enrollment>
  <condition>Metabolic Syndrome, Syndrome X, MetS,</condition>
  <condition>Diabetes Mellitus, Non-Insulin-Dependent</condition>
  <eligibility>
    <study_pop>
      <textblock>
        so-called &quot;Healthy-Workers&quot;, aged 25-60years, of Lufthansa-Technik, Hamburg, Germany, who
        voluntarily aggreed to participate in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  25-60 years men and women willing to give consent

        Exclusion Criteria:

          -  diabetes (type 1 or 2)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk Mueller-Wieland, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asklepios Klinik St.Georg, Hamburg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karl Wegscheider, Prof., PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universit채tsklinikum Hamburg Eppendorf, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asklepios Klinik St.Georg</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universit채tsklinikum Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <lastchanged_date>March 10, 2011</lastchanged_date>
  <firstreceived_date>March 10, 2011</firstreceived_date>
  <responsible_party>
    <name_title>1.Prof. Mueller-Wieland; 2.Prof.Wegscheider</name_title>
    <organization>1.Asklepios Klinik St.Georg, I.Med.; 2. Universit채tsklinikum HH-Eppendorf, Abtlg.f. Epidemiologie</organization>
  </responsible_party>
  <keyword>Metabolic Syndrome, Syndrome X, MetS,</keyword>
  <keyword>Type 2 Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
